Recent Publications

The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics
Journal of the European Academy of Dermatology and Venereology 2009
Christophers E, Barker JNWN, Griffiths CEM, Dauden E, Milligan G, Molta C, Sato R, Boggs R

The ISPOR Good Practices for Quality Improvement of Cost-effectiveness Research Task Force Report
Value in Health 2009;12(8)
McGhan WF, Maiwenn A, Doshi JA, Kamae I, Marx SE, Rindress D

Venous leg ulcers: patient concordance with compression therapy and its impact on healing and prevention of recurrence
International Wound Journal 2009;6(5):386-93.
Moffatt C, Kommala D, Dourdin N, Choe Y

Cost-effectiveness of atorvastatin 10 mg daily in the primary prevention of major cardiovascular events in patients with type 2 diabetes in Canada
Canadian Journal of Diabetes 2009;33(4):363-74.
Khoury H, Wagner M, Merikle E, Johnson SJ, Roberts C

Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: A systematic review of conclusions and assumptions
Vaccine 2009;27(36):4891-904.
Ogilvie I, El Khoury A, Cui Y, Dasbach E, Grabenstein JD, Goetghebeur M

Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis
Arthritis & Rheumatism 2009;61(11):1592-600.
Kavanaugh A, Smolen JS, Emery P, Purcaru O, Keystone E, Richard L, Strand V, vanVollenhoven RF

Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada
Canadian Journal of Clinical Pharmacology 2009;16(2):e331-e345.
Wagner M, Goetghebeur M, Pandya A, Merikle E, Chu P, Taylor DCA

Economic evaluation of high-dose (80 mg/day) atorvastatin treatment compared with standard-dose (20 mg/day to 40 mg/day) simvastatin treatment in Canada based on the Incremental Decrease in End-Points Through Aggressive Lipid-Lowering (IDEAL) trial
Canadian Journal of Cardiology 2009;25(11):e362-e369.
Wagner M, Lindgren P, Merikle E, Goetghebeur M, Jonsson B

Worksite health promotion: the value of the Tune Up Your Heart program
Population Health Management 2009;12(6):297-304.
Chung M, Melnyk P, Blue D, Renaud D, Breton M-C

Detection of Cognitive Impairment and Dementia Using the Animal Fluency Test: the DECIDE Study
Canadian Journal of Neurological Sciences 2009;36(5):599-604.
Sebaldt RJ, Dalzeil W, Massoud F, Tanguay A, Ward R, Thabane L, Melnyk P, Landry P, Lescrauwaet B

Post-marketing surveillance of the safety and effectiveness of etanercept in Japan
Journal of Rheumatology 2009:36(5);898-906
Koike T, Harigai M, Inokuma S, Ishiguro N, Inoue K, Ryu J, Takeuchi T, Tanaka Y, Yamanaka H, Fujii K, Freundlich B, Suzukawa M

Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: The COMET trial
Annals of the Rheumatic Diseases (published online 16 Mar 2009)
Kekow J, Moots R, Emery P, Durez P, Koenig A, Singh A, Pedersen R, Robertson D, Freundlich B, Sato R

A retrospective analysis of the prevalence and treatment of hypertension and dyslipidemia in southwestern Ontario, Canada
Clinical Therapeutics 2008;30(6):1145-54.
Petrella RJ, Merikle E

Chronic myeloid leukemia in Asia
International Journal of Hematology 2008;89(1):14-23.
Au WY, Caguioa PB, Chuah C, Hsu SC, Jootar S, Kim D-W, Kweon I-Y, O'Neil WM, Saikia TK, Wang J

Limitations of statin monotherapy for the treatment of dyslipidemia - a projection based on the Canadian Lipid Study Observational
Current Medical Research and Opinion 2008;25(1):47-55.
Senecal M, Fodor G, Gagné C, Genest J, Lavoie M-A, McPherson R, Marentette MA, Sebaldt RJ

Evidence and Value: Impact on DEcisionMaking - the EVIDEM framework and potential applications
BMC Health Services Research 2008;8:270.
Goetghebeur M, Wagner M, Khoury H, Levitt R, Erickson LJ, Rindress D

Fentanyl HCl iontophoretic transdermal system versus morphine IV-PCA for postoperative pain management: survey of healthcare provider opinion
Current Medical Research and Opinion 2008;25(2):293-301.
Bonnet F, Eberhart L, Wennberg E, Dodds S, VanBellinghen L, Annemans L, Kavanaugh S, Choe Y

Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE study
(includes editorial )
Canadian Respiratory Journal 2008;15(1):13-9.
Bourbeau J, Sebaldt RJ, Day A, Bouchard J, Kaplan A, Hernandez P, Rouleau M, Petrie A, Foster G, Thabane L, Haddon J, Scalera A

Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): A prospective community-based study
Canadian Journal of Infectious Disease and Medical Microbiology 2008;19(6):397-404.
Senecal M, Brisson M, the MIRAGE (Measuring the Impact of Rotavirus-Associated Gastroenteritis Episodes) study group, Lebel MH, Yaremko J, Wong R, Gallant L, Garfield HA, Abelman DJ, Ward RL, Sampalis J, Mansi JA

Top of page